> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Reorganizes Headquarters Organizations and Product Centers
- URL: https://www.fdaweb.com/fda-reorganizes-headquarters-organizations-and-product-centers/
- Published: 2019-05-20T12:00:00.000Z
- Updated: 2026-09-15T01:27:45.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144143

*Federal Register* notice: FDA has announced it has modified organizational structures in the Office of the Commissioner, headquarters organizations, and product Centers. The Office of the Commissioner reorganization will transition the agency away from the directorate structure to realign many functions to the Centers/Office of Regulatory Affairs (ORA). It also establishes a direct communication line between the Centers/ORA and the commissioner. The direct report relationship with the Centers streamlines communications and better positions FDA to support its regulatory programs and mission. The intent is to create a more effective structure that better reflects FDA’s priorities and streamlines operations. The CDRH reorganization will more accurately reflect the functions performed by the Center and help to enhance CDRH’s ability to advance FDA’s mission and streamline operations and support functions. The CDER reorganization changes the organizational structures and revises the functional statements of certain offices. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-05-20/pdf/2019-10431.pdf?ref=fdaweb.com).